Objective-The protein C anticoagulant pathway is an essential process for attenuating thrombin generation by the membrane-bound procoagulant complexes tenase and prothrombinase. In this pathway, protein S (PS) serves as a cofactor for activated protein C. PS circulates in plasma both in a free form and in complex with complement component 4b-binding protein (C4BP). C4BP is a known acute phase reactant, thereby suggesting a relation between PS and the acute phase response. Interleukin (IL)-6 has been shown to increase both PS and C4BP gene expression. Our objective was to study the regulation of PS gene expression by IL-6 in detail. Methods and Results-IL-6 upregulates both PS mRNA and protein levels in liver-derived HepG2 cells. The promoter of the PS gene (PROS1) was cloned upstream from a luciferase reporter gene. After transfection in HepG2 cells, the luciferase activity was shown to be stimulated by the addition of IL-6. IL-6 exerts its effect through Signal Transducer and Activator of Transcription 3 (STAT3) that interacts with the PROS1 promoter at a binding site in between nucleotides 229 to 207 upstream from the translational start.
T he protein C anticoagulant pathway is indispensable in maintaining the hemostatic balance. 1, 2 In this pathway, protein S (PS) functions as a nonenzymatic cofactor for activated protein C in the inactivation of coagulation factors VIIIa and Va. [3] [4] [5] [6] The clinical importance of PS became apparent by the association of venous thrombo-embolism with (partial) PS deficiency. [7] [8] [9] The major source of circulating plasma PS is the hepatocyte. 10 In human plasma, PS circulates in an active free form (40%) and a C4b-binding protein (C4BP)-bound inactive form (60%). [11] [12] [13] The acute phase response (APR) is characterized by a rapid increase of hepatic proteins, which serves to restore the physiological balance and limit the deleterious effects of tissue injury and infection. In the liver, synthesis of several plasma proteins, eg, ␣1-antitrypsin, ␣2-macroglubulin, plasminogen, and fibrinogen, undergoes dramatic changes during the APR. 14 Several of these proteins are also involved in coagulation or fibrinolysis. The changes during the APR are mainly mediated by the action of cytokines, such as interleukin (IL)-6, IL-1␤, and tumor necrosis factor (TNF)-␣.
In vitro studies in cultured human hepatoma cell line HepG2, primary human umbilical vein endothelial cells, and in the human microvascular endothelial cell line HMEC-1, have shown increased PS production on IL-6 stimulation. [15] [16] [17] C4BP is an established acute phase reactant with 2-to 3-fold elevated plasma levels during inflammation. 18 -21 The C4BP protein contains 6 or 7 identical ␣-chains and a single ␤-chain, although 17% of the C4BP molecules lack the ␤-chain. 13 PS is bound to C4BP via the ␤-chain. Several studies have demonstrated similar or slightly increased total PS levels, but reduced free PS levels in plasma of patients during inflammation. [22] [23] [24] The observed reduction in free PS levels has been explained as a direct consequence of an increase in the ␤-chain containing C4BPform. Other studies, however, provide evidence for stable free PS levels during inflammation, showing only a rise in C4BP ␣-chain levels, but not in ␤-chain levels. 21, 25 The observed discrepancy between the various studies may be explained by a differential regulation of C4BP ␣and ␤-chains in different subpopulations of patients during the APR. 26 The IL-6 signaling pathway is well-defined. [27] [28] [29] In short, IL-6 is known to exert its stimulatory effect through IL-6 -responsive elements (IL-6-RE) in the promoters of IL-6 -responsive genes. Two types of IL-6-REs have been identified in genes encoding acute phase proteins. Type I is a binding site for CCAAT/ enhancer binding protein (C/EBP) ␤ (NF-IL6, LAP), whereas the type II IL-6-RE is bound by Signal Transducer and Activator of Transcription 3 (STAT3). 30 Although IL-6 upregulates nuclear C/EBP␤ levels through both elevated C/EBP␤ gene transcription and C/EBP␤ phosphorylation, 29 increased nuclear STAT3 levels are mainly attributable to rapid STAT3 phosphorylation. 28 C/EBP␤ and STAT3 have been shown to affect IL-6 -induced transcription by binding to, among others, the promoters of the genes encoding C-reactive protein, 31, 32 plasminogen, 33 haptoglobin, 34 and fibrinogen. 35 In this report we investigate the mechanism by which IL-6 upregulates PS protein levels.
Two copies of the PS gene are located on chromosome 3. The active PS gene (PROS1) shares 96% homology with the inactive pseudogene (PROS2). 36 -38 Recently, constitutive expression of the PROS1 promoter was shown to be regulated mainly by Sp1 in vitro, and to contain binding sites for various other transcription factors such as the hepatocyte-specific forkhead transcription factor FOXA2, which are possibly involved in tissuespecific or induced expression of the PROS1 promoter. 39, 40 We confirmed earlier findings that PS is upregulated by IL-6 in cultured HepG2 cells and complemented these with quantitative PS mRNA data thereby identifying the regulatory mechanism as pretranslational. Subsequently, we identified a region in the PS promoter spanning nucleotides 229 to 207 upstream from the translational start that binds STAT3, one of the nuclear messengers of IL-6.
Methods

Plasmids
The generation of PROS1 promoter reporter constructs is described in de Wolf et al. 40 PROS1 promoter constructs were mutated at a putative STAT3 binding site by use of the QuikChange XL Site-Directed Mutagenesis kit from Stratagene, with forward primer 5Ј-CCA GCT CCG AAA AGC CGC CTG GTG C TG TCC TTG TTA TCA C-3Јand reverse primer 5Ј-GTG ATA ACA AGG ACA GCA CCA GGC GGC TTT TCG GAG CTG G-3Ј. Successful incorporation of the mutations was confirmed by automated sequencing (Beckman).
Cell Culture
The human hepatoblastoma cell line HepG2 was purchased from the American Type Culture Collection (ATCC). Cells were grown in minimal essential medium (MEM), 10% fetal bovine serum (FBS), 100 g/mL penicillin, 100 g/mL streptomycin, and 1ϫ MEM nonessential amino acids (all purchased from Gibco, Invitrogen; Carlsbad, Calif, USA). For induction experiments, cells were washed twice with phosphate buffered saline, after which fresh medium was added that lacked FBS, but contained 0.1% human serum albumin and 5 or 100 ng/mL recombinant human IL6 (Strathmann; Hamburg, Germany).
Preparation of Nuclear Extracts
Nuclear extracts (NE) were prepared according to the method of Dignam et al. 41 The final nuclear extract buffer contained 20 mmol/L HEPES (pH 7.9), 0.2 mmol/L EDTA, 100 mmol/L KCl, 0.5 mmol/L DTT, 0.2 mmol/L PMSF and a 1ϫ concentration of an EDTA-free protease inhibitor cocktail (Roche). NE were aliquoted and frozen at Ϫ80°C until further use. Protein concentration of the NE was measured with the BCA assay (Pierce Biotech). NE were prepared from HepG2 cells cultured in the absence or presence (30 minutes or 14 hours) of 100 ng/mL IL-6.
Immunologic Detection of STAT3 and C/EBP␤
NE (10 g protein) were fractionated on a denaturing 7.5% polyacrylamide slab gel and transferred onto a nitrocellulose membrane. After blocking for 1 hour in phosphate-buffered saline (PBS) containing 1% nonfat dry milk, 1% bovine serum albumin, and 0.05% Tween 20, the membrane was incubated for 1 hour at room temperature with the first antibody. C/EBP␤, p-STAT3, and Sp1 were detected with the polyclonal antibodies sc-150G (1:1000), sc-7993 (1:1000), and sc-59 (1:1000), respectively (Santa Cruz Biotech). As secondary antibody, horseradish peroxidase-conjugated goat anti-rat IgG (Dako, Glostrup, Denmark) was used at a dilution of 1:1000. Enhanced chemoluminescence was used for detection by incubating the membrane for 1 minute with freshly mixed 1.25 mmol/L 3-aminophtalhydrazide, 0.2 mmol/L p-coumaric acid, and 0.01% v/v H 2 O 2 in 0.1 mol/L Tris-HCl pH 8.5.
Reporter Gene Assays
Cells were transfected at 60% to 80% confluence. Each transfection was performed in triplicate in 12-wells plates. All assays were conducted with 2 different DNA preparations of each construct. Transfections were carried out using 3 L Tfx-20 lipids (Promega) per g transfected DNA. In each transfection, an equimolar concentration of construct was used, supplemented with pUC13-MCS vector to obtain a fixed amount of transfected DNA. In pUC13-MCS the multiple cloning site had been removed by digestion with PvuII and religation. Control vector pRL-SV40 (Promega), expressing the Renilla luciferase, was cotransfected for correction of transfection efficiency in a 1:500 ratio to total transfected DNA. The cell extracts were harvested at 24 hours (HepG2) after transfection. During induction experiments, medium was aspirated and replaced by fresh medium with or without IL-6 eight hours after transfection and cell extracts were harvested 48 hours after IL-6 addition. Luciferase activity was measured according to the Dual Luciferase Assay System Protocol (Promega). Cells were lysed in 250 L Passive Lysis Buffer/well, after which 20 L was used to measure luciferase activity. Activity was measured using a Lumat LB9507 luminometer (Berthold, Bad Wildbad, Germany).
PS Measurements
Total PS antigen levels in IL-6 -stimulated and unstimulated culture media were determined by enzyme-linked immunosorbent assay (ELISA) as described previously 42 with the following modifications. ELISA plates were coated with 10 g/mL goat anti-human PS IgG (Kordia, Leiden, The Netherlands) overnight at 4°C. A second coating with 2.5% ovalbumin (Sigma-Aldrich) at 37°C for 1 hour was performed to reduce background absorbance. Immobilized PS was detected with horseradish peroxidase-conjugated rabbit anti-human IgG (Dako, Glostrup, Denmark). Absorbance at 450 nm was determined with an Organon Teknika plate reader (Turnhout, Belgium).
RNA Assays
Total RNA was isolated from cell culture using Trizol reagent (Invitrogen) according to the manufacturer's recommendations. Samples were treated with RNAse-free DNAse I (Amersham) after which RNA was purified with an RNeasy mini kit (Qiagen). PROS1 mRNA levels were determined by real-time quantitative polymerase chain reaction (qPCR) analysis. First, 1 g total RNA from each cell line was reverse transcribed using Superscript II reverse transcriptase and random hexamers (Invitrogen). 1/20th of the obtained cDNA was subsequently used in a qPCR reaction with primers and probes specific for PROS1. The forward primer was 5Ј-TGC TGG CGT GTC TCC TCC TA-3Ј, the reverse primer was 5Ј-CAG TTC TTC GAT GCA TTC TCT TTC A-3Ј, the probe was TET-5Ј-CTT CCC GTC TCA GAG GCA AAC TTT TTG TC-3Ј-TAMRA. The primers and probe sequence locations and lengths were determined by using the ABI Primer Express Program (Applied Biosystems). PROS1 qPCR reactions (Eurogentec) were performed in 0.5 mL thin-walled, optical-grade qPCR tubes (Applied Biosystems) in a 50 L final volume, by addition of the following components: 0.25 U AmpliTaq Gold DNA polymerase, 160 nM TaqMan probe, 300 nM of each primer, and 3 mmol/L MgCl 2 . A qPCR of the internal standard, the porphobilinogen deaminase gene (PBGD), was carried out in a similar fashion for each RNA sample with 4 mmol/L MgCl 2 . For this qPCR the following primers and probe were used: forward primer 5Ј-GGC AAT GCG GCT GCA A-3Ј, reverse primer 5Ј-GGG TAC CCA CGC GAT CAC-3Ј, and probe TET-5Ј-CTC ATC TTT GGG CTG TTT TCT TCC GCC-3Ј-TAMRA. An Applied Biosystems Prism model 7700 instrument monitored the reactions. Thermal cycling conditions consisted of 10 minutes at 95°C followed by 50 cycles of 15 s at 95°C and 1 minute at 60°C. Determinations of cycle threshold (C T ) were performed automatically by the instrument. The results are expressed as fold transcript relative to the internal standard PBGD (ϭ2 ⌬Ct ).
Electrophoretic Mobility Shift Assays
Electrophoretic mobility shift assays (EMSAs) were performed in a 13-L binding reaction containing 10 g NE and 195 ng denatured herring sperm DNA. EMSA buffers were purchased from Active Motif and used according to the manufacturer's recommendations. Doublestranded (ds) oligonucleotides were end-labeled using ␥ 32 P-ATP and T4 polynucleotide kinase. The following ds oligonucleotides were used (only the sense strand is given): Ϫ229/Ϫ207wt 5Ј-AAA AGC TTC CTG GAA ATG TCC TTG-3Ј, Ϫ229/Ϫ207mt 5Ј-AAA AGC CGC CTG GTG CTG TCC TTG-3Ј, STAT3cons 5Ј-GAT CCT TCT GGG AAT TCC TAG ATC-3Ј, C/EBP␤cons 5Ј-TGC AGA TTG CGC AAT CTG CA-3Ј. Reaction mixtures were incubated on ice for 20 minutes in the presence or absence of an unlabeled competitor. Subsequently, the 32 P-labeled ds probe was added and the incubation was continued for another 20 minutes. In antibody supershift experiments, NE was incubated on ice for 10 minutes with the 32 P-labeled ds probe after which an anti-STAT3 or anti-cEBP␤ antibody (Santa Cruz Biotechnology) was added and the incubation was allowed to continue for another 10 minutes. Samples were loaded on a 5% nondenaturing polyacrylamide gel, which was electrophoresed for 2 hours at 200V, after which gels were vacuum dried and exposed to X-ray film.
Results
IL-6 Induces PROS1 mRNA and PS Protein Levels in HepG2
PS circulates in normal plasma at a concentration of about 0.33 mol/L. 13 Hepatocytes are the largest contributor to the systemic levels of PS 10 ; therefore, hepatoma cell line HepG2 was used as a model system. PS mRNA and protein levels under basal culture conditions were compared with those after induction with 5 or 100 ng IL-6 per ml culture medium (Figure 1) . A dose-dependent increase in PS mRNA and protein levels became detectable after 16 hours of IL-6 treatment of HepG2 cells. After this time, mRNA levels remained similar, but PS continued to accumulate in the medium up to at least 48 hours after the addition of IL-6. Total fibrinogen antigen levels were measured as a positive control. Fibrinogen is an established acute phase reactant, [43] [44] [45] and its levels increased from 3.5 nM to 8.6 or 16.6 nM after induction with 5 or 100 ng/mL IL-6 for 24 hours, respectively.
Phosphorylation of STAT3 is Induced and Maintained by IL-6 in HepG2 Cells
The signal transduction pathway of IL-6 signal has 2 main cellular targets: the transcription factors STAT3 and C/EBP␤ that mediate most of the IL-6 -induced alterations in gene expression. Strongly increased nuclear STAT3 levels stimulate transcription of target genes and are attributable to rapid STAT3 phosphorylation by janus kinases (JAKS) that are stimulated by binding of IL-6 to its cognate receptor. 28 As a consequence, induction of gene transcription by binding of phosphorylated STAT3, which leads to dimerization, occurs rapidly after IL-6 signaling. On the other hand, increased C/EBP␤ activity is achieved by enhanced transcription of the structural gene as well as by phosphorylation of the protein 29 ; hence, increased trans-activation of gene promoters by C/EBP␤ generally occurs later in time and lasts longer. 46 Therefore, we tested NE from HepG2 cells, which had been stimulated with IL-6, for the presence of both C/EBP␤ and phosphorylated STAT3 (Figure 2 ). Whereas C/EBP␤ levels remained similar, phosphorylated STAT3 levels were increased at both time points tested, 30 minutes and 14 hours. The presence of strong STAT3 phosphorylation after 14hours incubation with IL-6 is in concordance with the sustained PROS1 mRNA induction.
An IL-6 Responsive Element is Present in the PROS1 Promoter
Subconfluent HepG2 cells were transfected with promoterreporter gene plasmids containing a PROS1 5Ј region of varying length, after which the cells were either induced with IL-6, or grown further under basal conditions (Figure 3a) . A PROS1 promoter region of 261 bp remained IL-6 -responsive. However, transfections with the shortest promoterreporter gene construct, PS197, did not result in increased luciferase levels on IL-6 induction. These results indicate that an IL-6 -responsive element within the PROS1 promoter is located between 261 and 197 bp upstream from the translational startcodon. The stimulatory effect of IL-6 on PS261 was not augmented with increasing promoter size.
The IL-6 Response is Mediated by Binding of STAT3 to the IL6-RE in the PROS1 Promoter
Computational analysis using various databases on the internet such as MatInspector professional (hhtp://www.genomatix. com), Transfac (http://www.gene-regulation.com), and tfsitescan (http://www.ifti.org) showed that both a STAT3 and a C/EBP␤ binding consensus are located in the Ϫ261 to Ϫ197 bp region in the PROS1 promoter ( Figure 3b ).
Increased binding of a protein complex to a ds oligonucleotide probe, Ϫ229/Ϫ207wt, overlapping this region was observed in extracts from IL-6 -treated HepG2 cells ( Figure  4, left panel) . The majority of this protein-DNA complex was shifted with a STAT3 antibody, leaving a weak signal at the original location.
The mutated unlabeled ds oligonucleotide, Ϫ229/Ϫ207mt, was unable to compete with the PS wild-type probe for protein binding, whereas unlabeled ds oligonucleotides Ϫ229/Ϫ207wt and STAT3cons containing the PROS1 wild-type STAT3 site and the STAT3 consensus sequence were efficient competitors ( Figure 4 ). The C/EBP␤ consensus oligonucleotide did not influence protein binding to the Ϫ229/Ϫ207 probe. However, a slight shift from the original complex in NE from untreated HepG2 cells was observed with a C/EBP␤ antibody, suggesting 4 . EMSA of the IL-6 -resposive element in the PROS1 promoter. EMSA using a double-stranded oligonucleotide representing the IL-6 -responsive element and using NE from HepG2 cells treated with or without 100 ng/mL IL-6. The location of the IL-6 -specific band is indicated by an arrow. Nonlabeled double-stranded competitor oligonucleotides were used at 100-fold molar excess. wt indicates wild-type, mt, mutant, cs1 is a STAT3 consensus oligonucleotide, cs2 is a C/EBP␤ consensus oligonucleotide (see the Methods section for the sequences of the oligonucleotides). Antibody 1 was a STAT3-specific antibody and antibody 2 was a C/EBP␤ specific antibody.
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that the residual band present at the original location in the STAT3 supershift might contain comigrating C/EBP␤-probe complexes (Figure 4 , right panel). The expression of mutated promoter-reporter gene constructs in HepG2 cell culture was analyzed to investigate the contribution of STAT3 and possibly C/EBP␤ to transcriptional upregulation of PS levels during IL-6 induction. Although basal promoter activity remained unaltered on mutation of the Ϫ229/ Ϫ207 region, the mutations resulted in abolishment of the IL-6 response in all promoter-reporter gene constructs ( Figure 5 ). This underlines our preliminary conclusion from the data obtained with the wild type PROS1-reporter gene constructs that the site at Ϫ229/Ϫ207 is the only IL-6-RE in the proximal PROS1 promoter.
Discussion
Plasma proteins that are upregulated during the APR can be roughly divided into 3 major groups: proteins with an increased level of about 50% (eg, ceruloplasmin and complement factor-3), those with an increase of 2-to 3-fold (haptoglobin, fibrinogen, C4BP), and a group of proteins which responds with a rapid increase of 5-fold to up to 1000-fold (C-reactive protein and serum amyloid A protein). 18, [47] [48] [49] [50] We found a 2-fold increase in PS levels in the medium after 48 hours incubation of HepG2 cell culture with 5 ng IL-6 per ml medium (Figure 1) , which is in agreement with a previous report. 15 Both PROS1 mRNA as well as PS protein levels were elevated up to 48 hours of IL-6 stimulation. Protein S thus seems to belong to the second category of acute phase proteins.
The fact that not only PS protein levels but also PROS1 mRNA levels were upregulated by IL-6 indicated that IL-6 acted at the transcriptional level. Because IL-6 induction is known to be mediated primarily by STAT3 and C/EBP␤, we tested the levels of these 2 transcription factors in IL-6induced NE and found that total C/EBP␤ levels remained unchanged throughout time, whereas phosphorylated STAT3 levels were increased, also after prolonged IL-6 stimulation (Figure 2 ). This result is in concordance with the sustained higher PS levels in IL-6 -treated versus untreated HepG2 cell culture.
In this study, we identified an IL-6-RE in the PROS1 promoter at a region Ϸ220 bp upstream from the PROS1 translational start codon. This region contains both the hallmarks of the STAT3 and the C/EBP␤ binding sites (Figure 3 ). We identified STAT3 as the main transcription factor binding to the IL-6-RE ( Figure 4 ). C/EBP␤ may also bind to this region, but its contribution appears to be relatively minor. Mutation of the STAT3 binding site in the PROS1 promoter completely abolished the IL-6 response in transfection experiments with promoter-reporter gene constructs ( Figure 5 ). This indicates that there are no additional functional STAT3 or C/EBP␤ binding sites through which the IL-6 effect is mediated in the region investigated. The putative overlap between the STAT3 and the C/EBP␤ binding sites around position Ϫ220 makes it difficult to make definitive statements about the role of the latter protein in the induction of PROS1 transcription in HepG2 cells. Overlapping binding sites might constitute an efficient way to create an IL-6 -responsive element that is active both at early and late time points of IL-6 stimulation.
Although PROS1 is clearly IL-6 -responsive in HepG2 cell culture, patient studies indicate that total systemic PS levels are only slightly increased or remain at a similar level during inflammation. Moreover, in a subpopulation of patients free PS levels are reduced during inflammation because of increased C4BP ␤-chain levels. 22 Also in patients with sepsis, free PS levels (measured as PS activity) were decreased. 51 In both circumstances, inflammation or sepsis, IL-6 is a major player and its induction of PS transcription does not apparently outweigh the above-mentioned in vivo effects. However, it could be argued that anticoagulation would even be worse if PROS1 transcription by IL-6 was not mildly induced. Nevertheless, the possibility that the main function of PROS1 transcriptional regulation by IL-6 may lie in another aspect of the inflammatory response should also be considered.
IL-6 has been implicated in a variety of cellular processes with a diverse array of regulatory roles. Dependent on the target cell, IL-6 may induce various and sometimes contrasting responses. For instance, IL-6 has a proinflammatory function and it can induce cytotoxic effects, but it is also a cell survival factor. Several studies have demonstrated the neuroprotective effects of IL-6, which are mediated by the stimulation of growth factors and STAT3. [52] [53] [54] [55] [56] Recently, Liu et al reported a neuroprotective effect of intravenously injected PS on cortical neurons during ischemic injury in mice. 57 The authors speculated that PS may be acting via a similar mechanism as its structural homologue, growth arrest-specific gene 6 (gas6), which induces cell survival through a signaling pathway mediated by the Tyro3/Axl membrane receptor family. Stimulation of local PS synthesis by IL-6 may therefore explain part of the cell survival properties reported for IL-6. In addition, increasing evidence suggests a function of PS in macrophage phagocytosis of apoptotic cells both directly 58, 59 and indirectly by directing complement to the surface of apoptotic cells. 60, 61 Exactly what this new role for PS entails has not yet been fully clarified. Based on the cited literature, it seems plausible that the upregulation by IL-6 of local and not systemic PS levels may contribute to processes such as the cell survival of cells in the inflamed region. Obviously, this hypothesis needs to be tested in future research.
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